https://www.selleckchem.com/pr....oducts/GSK429286A.ht
04); and recurrence of 25.4% in ES and 39.1% in BTS. The 3-year overall survival was significantly different between two groups (ES, 86.8%BTS, 58.8%), BTS is worse than ES (log-rank test; p 0.001). Venous invasion independently predicted worsened recurrence-free and overall survival. The vascular invasiveness was correlated with tumor progression after SEMS placement, and the survival rate was lower in BTS. SEMS potentially worsens prognostic outcomes in stage II-III obstructive colorectal cancer. The vascular invasiveness was c
Like
Comment
Share
